371 related articles for article (PubMed ID: 35590327)
1. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway.
Li L; Wang K; Liu Z; Lü Y; Wang C; Yi X; Guo J
World J Surg Oncol; 2022 May; 20(1):161. PubMed ID: 35590327
[TBL] [Abstract][Full Text] [Related]
2. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
Zhou W; Wu J; Zhu Y; Meng Z; Liu X; Liu S; Ni M; Jia S; Zhang J; Guo S
BMC Complement Med Ther; 2020 Jan; 20(1):6. PubMed ID: 32020871
[TBL] [Abstract][Full Text] [Related]
3. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
4. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
5. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
He R; Ou S; Chen S; Ding S
Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
[TBL] [Abstract][Full Text] [Related]
6. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
Gao J; Yang S; Xie G; Pan J; Zhu F
Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
[TBL] [Abstract][Full Text] [Related]
7. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
8. Research on the mechanisms of taraxerol for the treatment of gastric cancer effect based on network pharmacology.
Huo B; Song Y; Tan B; Li J; Zhang J; Zhang F; Chang L
Int J Immunopathol Pharmacol; 2022; 36():20587384211063962. PubMed ID: 34986036
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
Zhang LH; Zhang WY; Xiong JM; Duan XM; Hai LN; Zhang YL; Zhang MM; Qin GF; Zhang GW
Chin J Nat Med; 2022 Jan; 20(1):43-53. PubMed ID: 35101249
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
[TBL] [Abstract][Full Text] [Related]
11. Study on molecular biological mechanism of Chinese herbal medicines for the treatment of gastric precancerous lesions based on data mining and network pharmacology.
Zhang Q; Liu N; Wu D; Xu Z; Wang Y; Wang P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):573-584. PubMed ID: 36581572
[TBL] [Abstract][Full Text] [Related]
12. Study on the regulatory mechanism and experimental verification of icariin for the treatment of ovarian cancer based on network pharmacology.
Wang S; Gao J; Li Q; Ming W; Fu Y; Song L; Qin J
J Ethnopharmacol; 2020 Nov; 262():113189. PubMed ID: 32736044
[TBL] [Abstract][Full Text] [Related]
13. Compound Kushen injection attenuates angiotensin II‑mediated heart failure by inhibiting the PI3K/Akt pathway.
Wang W; Liu D; Yang L; Chen L; Miao M; Liu Y; Yin Y; Wei M; Liu G; An Y; Zheng M
Int J Mol Med; 2023 Mar; 51(3):. PubMed ID: 36734284
[TBL] [Abstract][Full Text] [Related]
14. An Advanced Systems Pharmacology Strategy Reveals
Zhou W; Wu C; Zhao C; Huang Z; Lu S; Fan X; Tan Y; Stalin A; You R; Liu X; Zhang J; Wu Z; Wu J
Front Cell Dev Biol; 2021; 9():742421. PubMed ID: 34646828
[TBL] [Abstract][Full Text] [Related]
15. Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-
Lei Y; Chan M; Liu H; Lyu W; Chen L; Zhong Y; Gan H; Wang M; Qi M; Guo Y; Liu J; Zhang E
Dis Markers; 2022; 2022():4399334. PubMed ID: 35899176
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
[TBL] [Abstract][Full Text] [Related]
17. The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
Li M; Zhang W; Yang L; Wang H; Wang Y; Huang K; Zhang W
Dis Markers; 2021; 2021():4304507. PubMed ID: 34306252
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Study to Investigate the Tumor-Suppressive Role of
Lv L; Du J; Wang D; Yan Z
Drug Des Devel Ther; 2024; 18():375-394. PubMed ID: 38347958
[TBL] [Abstract][Full Text] [Related]
19. Compound Kushen Injection inhibits epithelial-mesenchymal transition of gastric carcinoma by regulating VCAM1 induced by the TNF signaling pathway.
Huang Z; Wu C; Zhou W; Lu S; Tan Y; Wu Z; You R; Stalin A; Guo F; Zhang J; Liu P; Wang W; Duan X; You L; Wu J
Phytomedicine; 2023 Sep; 118():154984. PubMed ID: 37487253
[TBL] [Abstract][Full Text] [Related]
20. Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway.
Zhang G; Li Z; Dong J; Zhou W; Zhang Z; Que Z; Zhu X; Xu Y; Cao N; Zhao A
BMC Complement Med Ther; 2022 Jan; 22(1):10. PubMed ID: 35000605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
